Showing results (1-10 of 1,435) with videos related to
Sort By:
Pageof 144
Atherosclerosis. Supplements|January 30, 2013
Current standards in diagnosis and therapy of hyperlipoproteinemiaS Fischer, U Schatz, U JuliusAtherosclerosis. Supplements|May 5, 2015
Practical recommendations for the management of hyperlipidemiaS Fischer, U Schatz, U JuliusClinical Research in Cardiology Supplements|March 7, 2019
Lipoprotein(a)-an interdisciplinary challengeU Julius, S Tselmin, U Schatz, et al.Clinical Research in Cardiology Supplements|March 7, 2019
Lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 inhibitorsU Julius, S Tselmin, U Schatz, et al.Atherosclerosis. Supplements|November 4, 2017
Most significant reduction of cardiovascular events in patients undergoing lipoproteinapheresis due to raised Lp(a) levels - A multicenter observational studyU Schatz, S Tselmin, G Müller, et al.Atherosclerosis. Supplements|January 30, 2013
Iron deficiency and its management in patients undergoing lipoprotein apheresis. Comparison of two parenteral iron formulationsU Schatz, B Arneth, G Siegert, et al.Atherosclerosis. Supplements|May 5, 2015
Adverse events of lipoprotein apheresis and immunoadsorption at the Apheresis Center at the University Hospital DresdenJ Dittrich-Riediger, U Schatz, B Hohenstein, et al.Atherosclerosis. Supplements|January 30, 2013
Nicotinic acid as a lipid-modifying drug--a reviewU Julius, S FischerAtherosclerosis. Supplements|May 5, 2015
Effects of different lipoprotein apheresis methods on serum protein levelsU Julius, G Siegert, H Kostka, et al.Atherosclerosis. Supplements|November 4, 2017
Kinetics of Lipoprotein(a) in patients undergoing weekly lipoprotein apheresis for Lp(a) hyperlipoproteinemiaS Tselmin, G Müller, U Schatz, et al.Pageof 144